| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |